Compare BIO-TECHNE Corp (TECH) vs Advanced Drainage Systems Inc (WMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs Advanced Drainage Systems Inc — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while Advanced Drainage Systems Inc trades at $125.56 (market cap $9.51B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and Advanced Drainage Systems Inc pays the higher dividend (0.63%). Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and Advanced Drainage Systems Inc for 43 Days on average.
| TECH | WMS | |
|---|---|---|
Market Cap | $11.37B | $9.51B |
Volume | 3,153,511 | 771,064 |
Sector | Health | Basic Materials |
52-Week High | $72.61 | $175.38 |
52-Week Low | $43.31 | $125.33 |
Typical Hold Time | 63 Days | 43 Days |
Enterprise Value | $11.40B | $11.11B |
Dividend Yield | 0.44% | 0.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Advanced Drainage Systems (WMS) trades at $126.21, down 2.97% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news includes the release of its 2026 Sustainability Report and a quarterly dividend declaration.
The outlook is mixed; analyst consensus targets $188.70, implying significant upside, but near-term technical pressure and a projected net cash outflow in 2026 present risks. Investment appeal hinges on execution of growth initiatives and margin stability against macroeconomic and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →
